Is Atlassian (TEAM) Quietly Reframing Its Moat With Confluence’s New AI Remix Features?

• Earlier this week, Atlassian announced new AI-powered Confluence features, including Remix, which turns written content into visual artifacts, and pre-built agents that connect directly to Lovable, Replit, and Gamma without custom integrations.
• This move positions Confluence less as a static documentation tool and more as an AI-enabled content engine that can generate prototypes, applications, and presentations directly from existing knowledge.
• Now we’ll examine how Confluence’s new AI-driven Remix capabilities and partner agents could influence Atlassian’s existing investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Atlassian Investment Narrative Recap

To own Atlassian today, you need to believe its core collaboration and workflow tools will remain central to how teams plan, build, and document work, even as AI changes how software gets made. In the near term, the key catalyst is whether Atlassian’s growing AI layer can translate rising usage into clearer monetization, while the biggest risk remains that AI-driven automation could shrink traditional seat-based demand for tools like Jira and Confluence. Confluence Remix does not materially change that risk yet.

Among recent announcements, the February open beta of Jira AI agents stands out as closely related to the new Confluence Remix news. Together, Jira agents and Confluence partner agents extend Atlassian’s Rovo and MCP infrastructure across planning, execution, and documentation, which could deepen engagement with existing customers if these agents become embedded in day to day workflows. Whether that higher engagement ultimately supports pricing power or just adds cost remains an open question for the catalyst story.

Yet underneath the product excitement, investors should be aware that AI could still compress developer seat demand and...

Read the full narrative on Atlassian (it's free!)

Atlassian's narrative projects $9.3 billion revenue and $400.2 million earnings by 2029. This requires 17.1% yearly revenue growth and a $589.4 million earnings increase from -$189.2 million today.

Uncover how Atlassian's forecasts yield a $168.93 fair value, a 196% upside to its current price.

Exploring Other Perspectives

The most cautious analysts already assumed revenue of about US$8.6 billion and earnings of roughly US$212 million by 2028, but they still focused on cloud migration and rising low code competition as key threats. You and those bearish forecasts sit on the pessimistic end of expectations, and this latest AI push in Confluence may eventually shift how realistic that downside view looks.

Explore 10 other fair value estimates on Atlassian - why the stock might be worth just $83.41!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Atlassian research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Atlassian research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Atlassian's overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Uncover the next big thing with 33 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com